These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16793160)

  • 21. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.
    Konopka K; Fallah B; Monzon-Duller J; Overlid N; Düzgünes N
    Cell Mol Biol Lett; 2005; 10(3):455-70. PubMed ID: 16217556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibitory effect of ganciclovir on the HSV1-tk positive subcutaneous tumors transplanted with human ovarian cancer in nude mice].
    Xu C; Zhang X; Jin Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):709-11. PubMed ID: 9772430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of polyethylenimine-mediated transfection of suicide gene HSV-tk with an ovarian-specific promoter on growth of ovarian cancer cell line SKOV3].
    Jin P; Kong BH
    Ai Zheng; 2005 Jul; 24(7):806-11. PubMed ID: 16004805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamine depletion and cell cycle manipulation in combination with HSV thymidine kinase/ganciclovir cancer gene therapy.
    Wahlfors T; Karppinen A; Jänne J; Alhonen L; Wahlfors J
    Int J Oncol; 2006 Jun; 28(6):1515-22. PubMed ID: 16685452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus.
    Raki M; Hakkarainen T; Bauerschmitz GJ; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Oct; 14(19):1380-8. PubMed ID: 17611584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vivo HSV-TK gene transfer and the therapeutic effects of ganciclovir on bladder cancer in mice with HSV-TK gene transfer].
    Liu WC; Ye G; Zhang RG
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):41-2. PubMed ID: 12390841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficiency and specificity of ovarian cancer gene therapy in rats with a novel nonviral gene delivery system (GE7) via intraovarian artery perfusion approach.
    Jiang W; Xu CJ; Shao ZM; Zhou WJ; Ye B; Tian PK; Zhu JD; Gu JR
    Cancer Gene Ther; 2005 Oct; 12(10):810-7. PubMed ID: 15905861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
    Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Boucher PD; Ostruszka LJ; Murphy PJ; Shewach DS
    Gene Ther; 2002 Aug; 9(15):1023-30. PubMed ID: 12101433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y; Min T; Midan A; Ya C
    J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial cell transfection with cationic liposomes and herpes simplex-thymidine kinase mediated killing.
    Fife K; Bower M; Cooper RG; Stewart L; Etheridge CJ; Coombes RC; Buluwela L; Miller AD
    Gene Ther; 1998 May; 5(5):614-20. PubMed ID: 9797865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy.
    Seto M; Yamazaki T; Sonoda J; Matsumine A; Shinto Y; Uchida A
    Oncol Rep; 2002; 9(2):337-40. PubMed ID: 11836603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents.
    Tong X; Shine DH; Agoulnik I; Freund CT; Hasenburg A; Aguilar-Cordova E; Woo SL; Kieback DG
    Anticancer Res; 1998; 18(5A):3421-6. PubMed ID: 9858918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.